178 related articles for article (PubMed ID: 9617323)
1. [Analysis of 18 breast cancer patients with hypercalcemia].
Masuda N; Yayoi E; Furukawa J; Maruhashi S; Tokunaga M; Takiguchi S; Matsui S; Yano H; Tateishi H; Kinuta M; Maruyama H; Okamura J
Gan To Kagaku Ryoho; 1998 May; 25(6):845-51. PubMed ID: 9617323
[TBL] [Abstract][Full Text] [Related]
2. [Hypercalcemia in breast cancer].
Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
[TBL] [Abstract][Full Text] [Related]
4. [Somatostatin analogue treatment for malignant hypercalcemia associated with advanced breast cancer].
Shiba E; Inoue T; Akazawa K; Takai S
Gan To Kagaku Ryoho; 1996 Feb; 23(3):343-7. PubMed ID: 8712828
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates: clinical experience.
Coleman RE
Oncologist; 2004; 9 Suppl 4():14-27. PubMed ID: 15459426
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein MA; Coleman RE; Reitsma DJ; Chen BL; Seaman JJ
Cancer; 2003 Oct; 98(8):1735-44. PubMed ID: 14534891
[TBL] [Abstract][Full Text] [Related]
7. Management of hypercalcemia in breast cancer.
Theriault RL
Oncology (Williston Park); 1990 Feb; 4(2):43-6; discussion 50. PubMed ID: 2143669
[TBL] [Abstract][Full Text] [Related]
8. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
9. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
10. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
Adachi I; Kimura S; Yamaguchi K; Suzuki M; Abe K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
[TBL] [Abstract][Full Text] [Related]
11. Intravenous etidronate in the management of malignant hypercalcemia.
Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
[TBL] [Abstract][Full Text] [Related]
14. [Results of using Aredia for hypercalcemia in oncology patients].
Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV
Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606
[No Abstract] [Full Text] [Related]
15. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia in breast cancer.
Razis DV; Petounis AC; Constantoulakis MM
J Med; 1981; 12(1):63-9. PubMed ID: 6943266
[TBL] [Abstract][Full Text] [Related]
17. [Bone metastasis in advanced breast cancer].
Adachi I; Suzuki M; Tsuchihashi T; Yamaguchi K; Abe K
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1688-95. PubMed ID: 2954509
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
Coleman RE; Fogelman I; Rubens RD
Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer and concomitant primary hyperparathyroidism: description of two patients.
Kara IO; Sahin B; Yapar Z
Acta Med Austriaca; 2004 Aug; 31(3):81-4. PubMed ID: 15515483
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A
Prostate Cancer Prostatic Dis; 2009; 12(1):94-9. PubMed ID: 18332901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
